4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-108912
Chief Legal Officer sold 30,000 shares at an average $8.20 ($246,149)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazzariello Gina Chief Legal Officer | 2025-08-12 | Sale 10b5-1 | −15,000 | $8.07 | $121,103 | 171,969 | D |
| Mazzariello Gina Chief Legal Officer | 2025-08-13 | Sale 10b5-1 | −15,000 | $8.34 | $125,046 | 156,969 | D |
| Open-market sales · 30,000 sh · avg $8.20 · $246,149 | |||||||
Loading xslF345X05/ownership.xml…